Nurse Practitioner · Springfield, MA
NPI
1518449198
Since 2018
Specialty
Nurse Practitioner
Code 163W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1049 Main Street
Springfield, MA, 01103
Phone (413) 739-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
619 services
Medicare patients, 2024
323
Average age 69
Drug cost, 2024
$2.0M
5,191 prescriptions
Company payments, 2025
$842
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nataliya Sevastyanova was code 99214 (office e&m - established), 565 times for 313 patients. In total Nataliya Sevastyanova billed 619 services in 7 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 565 | 313 | $82.40 | $47K |
| 99406 Behavioral Health Services | Office | 33 | 27 | $12.46 | $411 |
By year: 2022 $40K for 536 services; 2023 $47K for 601 services; 2024 $49K for 619 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nataliya Sevastyanova prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 922 prescriptions and refills. In total Nataliya Sevastyanova wrote 5,191 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 922 | 1,039 | 298 | $29K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 704 | 1,083 | 143 | $681K |
| Montelukast Sodium Generic | 417 | 961 | 121 | $8,098 |
| Ventolin Hfa Albuterol Sulfate | 413 | 488 | 107 | $30K |
| Fluticasone Propionate Generic | 357 | 729 | 128 | $6,447 |
| Breo Ellipta Fluticasone/Vilanterol | 294 | 400 | 68 | $157K |
| Advair Hfa Fluticasone Propion/Salmeterol | 274 | 327 | 66 | $129K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 159 | 235 | 37 | $105K |
| Prednisone Generic | 128 | 136 | 64 | $537 |
| Azelastine Hcl Generic | 113 | 152 | 33 | $2,856 |
| Azithromycin Generic | 113 | 181 | 34 | $1,104 |
| Symbicort Budesonide/Formoterol Fumarate | 99 | 125 | 25 | $28K |
| Incruse Ellipta Umeclidinium Bromide | 88 | 139 | 23 | $48K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 87 | 107 | 20 | $67K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 86 | 137 | 27 | $15K |
Brand drugs: 3,389 claims; generic drugs: 1,802 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nataliya Sevastyanova $842 ($842 in general payments such as food, travel and fees) from 8 companies. The largest payer was GlaxoSmithKline, LLC. with $181.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.